April 4, 2018 / 3:08 PM / 3 months ago

BRIEF-Novartis says data show Entresto improves activity in HFrEF patients vs enalapril

April 4 (Reuters) - Novartis AG:

* NOVARTIS ANNOUNCES JAMA CARDIOLOGY PUBLICATION OF DATA SHOWING ENTRESTO IMPROVES PHYSICAL AND SOCIAL ACTIVITY IN HFREF PATIENTS VERSUS ENALAPRIL

* SAYS ‍IMPROVEMENT IN COMBINED PHYSICAL AND SOCIAL ACTIVITY OF PATIENTS TREATED WITH ENTRESTO VERSUS ENALAPRIL WAS EQUIVALENT TO A DIFFERENCE OF NINE YEARS OF AGING​

* SAYS ‍TREATMENT BENEFITS TO HEALTH-RELATED QUALITY OF LIFE (HRQL) WERE SEEN WITHIN EIGHT MONTHS AND PERSISTED AT THREE-YEAR FOLLOW UP PERIOD​ Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below